Belite Bio, Inc. ADR BLTE 深 沪
等待开盘 04-02 09:30:00 美东时间
167.25
+7.810
+4.90%
华盛通- 最 高167.83
- 今 开161.98
- 成交量 15.70万股
- 最 低 161.98
- 昨 收 159.44
- 总市值 65.80亿
- 52周最高 200.00
- 市盈率 静 --
- 换手率 0.40%
- 52周最低 53.595
- 委 比 -66.27%
- 总股本 3934.00万
- 历史最高 200.00
- 量 比 0.87
- 振 幅 3.67%
- 历史最低 8.80
- 每 手 1
- 风险率 46.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
Cantor Fitzgerald Maintains Overweight on Belite Bio, Raises Price Target to $266
Cantor Fitzgerald analyst Steve Seedhouse maintains Belite Bio (NASDAQ:BLTE) with a Overweight and raises the price target from $200 to $266.
03-03 22:30
Belite Bio Q4 EPS $(0.70) Misses $(0.54) Estimate
Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.54) by 29.15 percent. This is a 118.75 percent decrease over losses of $(0.32) per share from the
03-02 19:16
Earnings Scheduled For March 2, 2026
Companies Reporting Before The Bell • Zymeworks (NASDAQ:ZYME) is expected to re...
03-02 19:11
Exploring Belite Bio's Earnings Expectations
Belite Bio (NASDAQ:BLTE) is set to give its latest quarterly earnings report on...
02-28 00:00
美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
B of A Securities Initiates Coverage On Belite Bio with Buy Rating, Announces Price Target of $195
B of A Securities analyst Tazeen Ahmad initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $195.
01-26 19:57
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
Morgan Stanley Initiates Coverage On Belite Bio with Overweight Rating, Announces Price Target of $191
Morgan Stanley analyst Judah Frommer initiates coverage on Belite Bio (NASDAQ:BLTE) with a Overweight rating and announces Price Target of $191.
01-06 23:45
